Disease consequences of higher adiposity uncoupled from its adverse metabolic effects using Mendelian randomisation.
Saved in:
| Title: | Disease consequences of higher adiposity uncoupled from its adverse metabolic effects using Mendelian randomisation. |
|---|---|
| Authors: | Martin S; Institute of Biomedical and Clinical Science, University of Exeter Medical School, Research, Innovation, Learning and Development building, Royal Devon & Exeter Hospital, Exeter, United Kingdom., Tyrrell J; Institute of Biomedical and Clinical Science, University of Exeter Medical School, Research, Innovation, Learning and Development building, Royal Devon & Exeter Hospital, Exeter, United Kingdom., Thomas EL; Research Centre for Optimal Health, School of Life Sciences, University of Westminster, London, United Kingdom., Bown MJ; Department of Cardiovascular Sciences, University of Leicester, Leicester, United Kingdom.; NIHR Leicester Biomedical Research Centre, Leicester, United Kingdom., Wood AR; Institute of Biomedical and Clinical Science, University of Exeter Medical School, Research, Innovation, Learning and Development building, Royal Devon & Exeter Hospital, Exeter, United Kingdom., Beaumont RN; Institute of Biomedical and Clinical Science, University of Exeter Medical School, Research, Innovation, Learning and Development building, Royal Devon & Exeter Hospital, Exeter, United Kingdom., Tsoi LC; Department of Dermatology, University of Michigan, Ann Arbor, United States., Stuart PE; Department of Dermatology, University of Michigan, Ann Arbor, United States., Elder JT; Department of Dermatology, University of Michigan, Ann Arbor, United States.; Ann Arbor Veterans Affairs Hospital, Ann Arbor, United States., Law P; The Institute of Cancer Research, London, United Kingdom., Houlston R; The Institute of Cancer Research, London, United Kingdom., Kabrhel C; Department of Emergency Medicine, Massachusetts General Hospital, Boston, United States.; Department of Emergency Medicine, Harvard Medical School, Boston, United States., Papadimitriou N; Nutrition and Metabolism Branch, International Agency for Research on Cancer, Lyon, France., Gunter MJ; Nutrition and Metabolism Branch, International Agency for Research on Cancer, Lyon, France., Bull CJ; MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, United Kingdom.; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.; School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom., Bell JA; MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, United Kingdom.; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom., Vincent EE; MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, United Kingdom.; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom.; School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom., Sattar N; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom., Dunlop MG; University of Edinburgh, Edinburgh, United Kingdom.; Western General Hospital, Edinburgh, United Kingdom., Tomlinson IPM; Edinburgh Cancer Research Centre, IGMM, University of Edinburgh, Edinburgh, United Kingdom., Lindström S; Department of Epidemiology, University of Washington, Seattle, United States.; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, United States., Bell JD; Research Centre for Optimal Health, School of Life Sciences, University of Westminster, London, United Kingdom., Frayling TM; Institute of Biomedical and Clinical Science, University of Exeter Medical School, Research, Innovation, Learning and Development building, Royal Devon & Exeter Hospital, Exeter, United Kingdom., Yaghootkar H; Institute of Biomedical and Clinical Science, University of Exeter Medical School, Research, Innovation, Learning and Development building, Royal Devon & Exeter Hospital, Exeter, United Kingdom.; Research Centre for Optimal Health, School of Life Sciences, University of Westminster, London, United Kingdom.; Centre for Inflammation Research and Translational Medicine (CIRTM), Department of Life Sciences, Brunel University London, Uxbridge, United Kingdom. |
| Corporate Authors: | INVENT consortium |
| Source: | ELife [Elife] 2022 Jan 25; Vol. 11. Date of Electronic Publication: 2022 Jan 25. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. |
| Journal Info: | Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-084X (Electronic) Linking ISSN: 2050084X NLM ISO Abbreviation: Elife Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
